Department of Defense Awards Genomind Contract for Pharmacogenomics Consulting
KING OF PRUSSIA, Pa.–(BUSINESS WIRE)–Genomind, a leader in precision medicine and pharmacogenomic (PGx) testing, today announced it has been awarded a contract to support the Defense Health Agency’s (DHA) Research & Engineering (R&E) Directorate. The project, “Implementing and Assessing Pharmacogenomics for U.S. Active-Duty Service members,” is funded by the Congress through the FY24 Department of […]
Pharmacogenetics Predictors of Methylphenidate Efficacy in Childhood ADHD
Review pharmacodynamic literature in an effort to identify clinically significant predictors of methylphenidate (MPH) response in children.
Researchers Present New Data on the Utility of Genomind’s Mental Health Pharmacogenomic Testing at Upcoming Scientific Conferences
Researchers Present New Data on the Utility of Genomind’s Mental Health Pharmacogenomic Testing at Upcoming Scientific Conferences.
Genomind to Host Facebook Live Discussion During Mental Health Awareness Week
To kick off Mental Health Awareness Week, Genomind® patients will go live on Facebook to share about their experiences with Genomind’s Genecept Assay®.
New Research Suggests Genetic Testing May Help Improve Costs Associated with Mental Health Treatment
New research suggests genetic testing may help improve costs associated with mental health treatment.
More Americans Than Ever Embrace Genetic Testing To Aid In Mental Health Treatment, According To Annual Genomind® Mental Health Poll™
More Americans Than Ever Embrace Genetic Testing To Aid In Mental Health Treatment, According To Annual Genomind® Mental Health Poll™.
Penguin Random House Publishes Widely Praised Book Authored by Co-Founder of Genomind®
Penguin Random House Publishes Widely Praised Book Authored by Co-Founder of Genomind®.
Mental Health Awareness Month: Genomind® Recognizes Psychiatrist Who Made a Difference During Pulse Nightclub Tragedy
With May being Mental Health Awareness Month, Genomind is recognizing a psychiatrist whose dedication to helping patients went above and beyond.
Clinicians Treating Patients With Depression and Substance Abuse May Find Answers With Genetic Testing
An educational webinar explores how genetic testing can help clinicians with patients dealing with those who suffer from MDD and substance use disorder.
Americans Embrace Genetic Testing for Chronic Diseases, Yet Mental Illness Still Lags Behind Others, Survey Finds
According to the Genomind Mental Health Poll, Americans have divergent views about genetic testing for chronic diseases versus testing for mental illness.
Clinicians Prepare to Learn How Genomind’s Genecept Assay® Can Help in ADHD Treatment
Genomind will present an educational webinar for clinicians interested in learning how the test can help guide personalized ADHD treatment for patients.
Personalized Medicine for Mental Health Revolutionizes Care as Advocates Mark Mental Illness Awareness Week and World Mental Health Day
Personalized Medicine for Mental Health Revolutionizes Care as Advocates Mark Mental Illness Awareness Week and World Mental Health Day
Genecept Assay Open Label Trial Results Published In The Primary Care Companion For CNS Disorders
Genecept Assay Open Label Trial Results Published In The Primary Care Companion For CNS Disorders
New Evidence Shows Genetic Testing May Help Target Use of Antidepressants
New Evidence Shows Genetic Testing May Help Target Use of Antidepressants
Genomind Case Studies Published In Primary Care Companion For CNS Disorders
Genomind Case Studies Published In Primary Care Companion For CNS Disorders
Genomind White Paper Describing The Clinical Utility Of Pharmacogenetic Testing In Psychiatry Published In Psychiatry Journal
Genomind White Paper Describing The Clinical Utility Of Pharmacogenetic Testing In Psychiatry Published In Psychiatry Journal
Genomind To Exhibit At 2014 NEI Psychopharmacology Congress
Genomind To Exhibit At 2014 NEI Psychopharmacology Congress
Genomind To Attend The American Academy Of Child & Adolescent Psychiatry (AACAP) Annual Meeting
Genomind To Attend The American Academy Of Child & Adolescent Psychiatry (AACAP) Annual Meeting
Genomind To Exhibit At The APA Annual Meeting And The Clinical TMS Society Meeting
Genomind To Exhibit At The APA Annual Meeting And The Clinical TMS Society Meeting
Genomind To Exhibit At The American Academy Of Anti-Aging (A4M) Congress
Genomind To Exhibit At The American Academy Of Anti-Aging (A4M) Congress
Genomind To Attend and Exhibit At The AACAP Meeting
Genomind To Attend and Exhibit At The AACAP Meeting
Genomind To Participate In APNA Annual Conference
Genomind To Participate In APNA Annual Conference
Genomind Releases Statement Supporting NIMH Announcement To Move Away From DSM Categories
Genomind Releases Statement Supporting NIMH Announcement To Move Away From DSM Categories
Genomind To Participate In NAPHS Annual Meeting
Genomind To Participate In NAPHS Annual Meeting
Genomind To Spend Week Educating Industry Leaders
Genomind To Spend Week Educating Industry Leaders
Genomind To Exhibit At Two Upcoming Mental Health Conferences
Genomind To Exhibit At Two Upcoming Mental Health Conferences
Genomind To Participate In National Alliance On Mental Illness (NAMI) 2012 National Convention
Genomind To Participate In National Alliance On Mental Illness (NAMI) 2012 National Convention
Genomind Presents Open Label Study Protocol Designed To Assess The Genecept Assay In Actual Clinical Practice At American Psychiatric Association Annual Meeting
Genomind Presents Open Label Study Protocol Designed To Assess The Genecept Assay In Actual Clinical Practice At American Psychiatric Association Annual Meeting
Dr. Jay Lombard Of Genomind Selected To Speak At TEDMED 2012
Dr. Jay Lombard Of Genomind Selected To Speak At TEDMED 2012 On “The New Map For Mental Illness”
Schlosspark-Klinik Presents Successful Case History Using Genomind’S Genecept™ Assay At The German Association For Psychiatry And Psychotherapy 2011 Annual Meeting
Schlosspark-Klinik Presents Successful Case History Using Genomind’S Genecept™ Assay At The German Association For Psychiatry And Psychotherapy 2011 Annual Meeting